loader2
Partner With Us NRI

Wanbury Ltd share Price Today

Company details

157.50
157.50
42.65
179.35
6M Return 75.68%
1Y Return 229.15%
Mkt Cap.(Cr) 515.73
Volume 48,174
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 48,174

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Wanbury Ltd shares SWOT Analysis

Strengths (7)

  • MACD Crossover Above Signal Line
  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with high TTM EPS Growth

Weakness (3)

  • Red Flag: High Interest Payments Compared to Earnings
  • Low Piotroski Score : Companies with weak financials
  • Companies with High Promoter Pledge

Opportunity (3)

  • Highest Recovery from 52 Week Low
  • Stock with Low PE (PE < = 10)
  • RSI indicating price strength

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 157.5
R2 157.5
R3 157.5
Pivot

157.50

S1 157.5
S2 157.5
S3 157.5
EMA SMA
147.4
148.1
140.3
120.5
148.7
148.3
147.4
112.8
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ELIZABETH MATHEW Bulk Sell 2024-01-09 133.04 190000 NSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 2023-10-20 88.5 202818 NSE
GANITA TECHNOLOGIES AND SERVICES PRIVATE LIMITED Bulk Purchase 2023-05-04 52.7 219753 BSE
Name Category Shares
EXPERT CHEMICALS (INDIA) PVT LTD PROMOTER 30.56%
KINGSBURY INVESTMENTS INC. PROMOTER 9.23%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Wanbury Ltd Stocks COMPARISON

Financials( in Cr) Wanbury Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Zydus Lifesciences Ltd Divis Laboratories Ltd
Price 157.50 1,531.40 1,399.05 1,051.40 3,910.75
% Change 10.22 0.26 -0.54 5.45 0.47
Mcap Cr 515.73 367,434.16 112,954.68 105,795.44 103,818.29
Revenue TTM Cr 499.65 43,885.68 15,790.60 17,237.40 7,767.51
Net Profit TTM Cr -10.40 8,560.84 2,513.47 1,997.30 1,823.38
PE TTM 16.93 39.17 26.53 27.46 75.08
1 Year Return 229.15 60.69 51.61 103.07 19.36
ROCE 0.00 16.79 14.76 16.25 19.30
ROE 0.00 16.46 10.66 14.05 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: -32.81 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 45,581.63 -35,822.31
LAST 3M 105,886.10 -42,131.07
LAST 6M 173,680.57 48,055.67
LAST 12M 265,486.86 128,722.00
Wanbury Limited - Press Release

May 17, 2024 l NSE Announcement

NSE Board Meetings Forthcomming

May 16, 2024 l NSE Board Meetings Forthcomming

Board Meeting for Today

May 16, 2024 l Board Meetings for Today

Date Action Type Ratio
No data found

Wanbury Ltd Information

Stock PE (TTM)
16.93
Promoter Holding
39.79%
Book Value
8.4983
ROCE
0%
ROE
0%
Description
  • Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988. The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Hon`ble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/- each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively. The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008. The novel product `Cdense Gems` was launched in May, 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched, Myotol-F, targeted at female infertility in 2013, it launched Folinine. The Company`s newly launched products Myotol-F (to treat polycystic ovarian syndrome) and Cal-K2 (in prevention and management of Osteoporosis) were labelled as one of the best launches in 2014.

Registered Address

BSEL Tech Park B-Wing 10th Flr, Sector 30 A Opp Vashi Rly Stat, Navi Mumbai, Maharashtra, 400703

Tel : 91-22-67942222
Email : shares:wanbury.com; jitendra.gandhi:wanbury.com
Website : http://www.wanbury.com
Registrar

Sharex Dynamic (India) Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524212
NSE Code : WANBURY
Book Closure Date (Month) : Sep
BSE Group : T
ISIN : INE107F01022

FAQ’s on Wanbury Ltd Shares

You can buy Wanbury Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Wanbury Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 17, 2024 03:57 PM the closing price of Wanbury Ltd was Rs.157.50.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 17, 2024 03:57 PM, the market cap of Wanbury Ltd stood at Rs. 515.73.

The latest PE ratio of Wanbury Ltd as of May 17, 2024 03:57 PM is 16.93

The latest PB ratio of Wanbury Ltd as of May 17, 2024 03:57 PM is 0.05

The 52-week high of Wanbury Ltd share price is Rs. 179.35 while the 52-week low is Rs. 42.65

Download App

Download Our App

Play Store App Store
market app